The Robert Brigham Multidisciplinary Clinical Research Center (RBMCRC) is the principal resource for clinical, translational, epidemiological, health services and methodological research on rheumatologic and musculoskeletal conditions at the Brigham and Women's Hospital and throughout the Harvard Medical and Public Health communities. The Center is a hub for clinically- and policy-relevant, methodologically rigorous, interdisciplinary research to improve the outcomes of patients with musculoskeletal and rheumatologic disorders. The objectives of the Center are to: 1) Perform cutting edge research on rheumatologic and musculoskeletal problems in order to prevent these disorders, improve their management, enhance quality of life for patients with these problems and optimize provision of services for patients with rheumatic and musculoskeletal disorders. 2) Provide core methodologic and administrative resources and scientific leadership to catalyze such research among Center investigators and throughout the Center's research base. 3) Enhance the career development of younger investigators dedicated to the application of rigorous clinical research methodology to problems affecting the quality of life of persons with rheumatic and musculoskeletal disorders. The Center is structured around a Methodology Core, which ensures rigorous design and execution of research, and an Administrative Core, which provides effective scientific leadership, financial management and oversight. The Center proposes three projects: 1) """"""""Suboptimal outcomes of total knee replacement: Phenotypes and Risk factors;"""""""" 2) """"""""Rheumatic expertise expanded access to improve community health;"""""""" and, 3) """"""""Communication of biomarker, genetic and lifestyle risk factor profiles for RA to first degree relatives."""""""" Each ofthe projects applies rigorous methods to address pressing priorities in rheumatic and musculoskeletal disease: optimizing outcomes of total knee replacement, a procedure performed on more than 600,000 Americans each year;ensuring that primary care physicians and rheumatologist collaborate effectively to provide appropriate medications to patients with rheumatoid arthritis (RA);and anticipating the emergence of RA prevention by developing methods to communicate RA risk and preventive behavioral strategies to first degree relatives of persons with rheumatoid arthritis.
The Robert Brigham Multidisciplinary Clinical Research Center is dedicated to methodologically rigorous, clinically relevant clinical research on rheumatic and musculoskeletal conditions. The Center proposes three projects relating to key priorities: optimizing outcomes of total knee replacement, ensuring appropriate treatment of rheumatoid arthritis (RA) and effectively communicating risk of RA to first degree relatives.
|Zak, Agnes; Corrigan, Cassandra; Yu, Zhi et al. (2018) Barriers to treatment adjustment within a treat to target strategy in rheumatoid arthritis: a secondary analysis of the TRACTION trial. Rheumatology (Oxford) 57:1933-1937|
|von Heideken, Johan; Iversen, Maura D; Gerdhem, Paul (2018) Rapidly increasing incidence in scoliosis surgery over 14 years in a nationwide sample. Eur Spine J 27:286-292|
|MacFarlane, Lindsey A; Yang, Heidi; Collins, Jamie E et al. (2018) Relationship between patient-reported swelling and MRI-defined effusion-synovitis in patients with meniscus tears and knee osteoarthritis. Arthritis Care Res (Hoboken) :|
|Sparks, Jeffrey A; Lin, Tzu-Chieh; Camargo Jr, Carlos A et al. (2018) Rheumatoid arthritis and risk of chronic obstructive pulmonary disease or asthma among women: A marginal structural model analysis in the Nurses' Health Study. Semin Arthritis Rheum 47:639-648|
|Kreps, David J; Halperin, Florencia; Desai, Sonali P et al. (2018) Association of weight loss with improved disease activity in patients with rheumatoid arthritis: A retrospective analysis using electronic medical record data. Int J Clin Rheumtol 13:1-10|
|Solomon, Daniel H; Lu, Bing; Yu, Zhi et al. (2018) Benefits and Sustainability of a Learning Collaborative for Implementation of Treat-to-Target in Rheumatoid Arthritis: Results of a Cluster-Randomized Controlled Phase II Clinical Trial. Arthritis Care Res (Hoboken) 70:1551-1556|
|Prado, Maria G; Iversen, Maura D; Yu, Zhi et al. (2018) Effectiveness of a Web-Based Personalized Rheumatoid Arthritis Risk Tool With or Without a Health Educator for Knowledge of Rheumatoid Arthritis Risk Factors. Arthritis Care Res (Hoboken) 70:1421-1430|
|Lee, Moa P; Lii, Joyce; Jin, Yinzhu et al. (2018) Patterns of Systemic Treatment for Psoriatic Arthritis in the US: 2004-2015. Arthritis Care Res (Hoboken) 70:791-796|
|Barbhaiya, Medha; Tedeschi, Sara K; Lu, Bing et al. (2018) Cigarette smoking and the risk of systemic lupus erythematosus, overall and by anti-double stranded DNA antibody subtype, in the Nurses' Health Study cohorts. Ann Rheum Dis 77:196-202|
|Sparks, Jeffrey A; Iversen, Maura D; Yu, Zhi et al. (2018) Disclosure of Personalized Rheumatoid Arthritis Risk Using Genetics, Biomarkers, and Lifestyle Factors to Motivate Health Behavior Improvements: A Randomized Controlled Trial. Arthritis Care Res (Hoboken) 70:823-833|
Showing the most recent 10 out of 444 publications